MRC1 and nervous system disorder: Previous studies have demonstrated that CD16/32-expressing microglial cells promote a pro-inflammatory response, while CD206-expressing microglial cells mediate an anti-inflammatory response in several neurological diseases, such as ischemic stroke and brain trauma [22, 53, 54].